You reviewed ....
for this content
out of 5
Event : ESC Congress 2015
Topic : Pharmacology and Pharmacotherapy
Angiotensin receptor neprilysin inhibition and renal function and in heart failure: results from PARADIGM-HF
ESC Congress 2015
Effect of LCZ696 on urinary albumin excretion and relation to outcomes in patients with heart failure
Beta-blocker therapy and in-hospital outcome in acute heart failure: a propensity-score matching secondary analysis of the ALARM-HF registry
Hydrophilic versus lipophilic statin therapy on outcomes in patients with heart failure: a systematic review and an adjusted indirect comparison meta-analysis of randomised trials
Carperitide versus nitroglycerin as a first-line therapy in patients with acute heart failure: a propensity-matched comparison.
ONO-4232, an EP4-selective agonist, improves left ventricular diastolic dysfunction in chronic heart failure model
Bendavia, a novel mitochondria-targeting peptide, improves contraction and relaxation of failing cardiomyocytes isolated from dogs with chronic heart failure
Hepato-renal dysfunction on admission predicts the outcome in acute heart failure.
Predictors, treatment and long-term course of iron deficiency in unselected patients with heart failure: The RAID-HF registry
RA123456, a novel potent and selective CaMKII inhibitor reduces diastolic Ca2+ leak and enhances SR Ca2+ content in human cardiomyocytes
Get your access to resources
Our mission: To reduce the burden of cardiovascular disease